147 related articles for article (PubMed ID: 23771927)
1. Single modification at position 14 of siRNA strand abolishes its gene-silencing activity by decreasing both RISC loading and target degradation.
Zheng J; Zhang L; Zhang J; Wang X; Ye K; Xi Z; Du Q; Liang Z
FASEB J; 2013 Oct; 27(10):4017-26. PubMed ID: 23771927
[TBL] [Abstract][Full Text] [Related]
2. D-Isonucleotide (isoNA) incorporation around cleavage site of passenger strand promotes the vibration of Ago2-PAZ domain and enhances in vitro potency of siRNA.
Huang Y; Tian M; Zhang Y; Sheng G; Chen Z; Ma Y; Chen Y; Peng Y; Zhao YL; Wang Y; Zhang L; Yang Z
Org Biomol Chem; 2015 Nov; 13(44):10825-33. PubMed ID: 26313718
[TBL] [Abstract][Full Text] [Related]
3. Re-Engineering RNA Molecules into Therapeutic Agents.
Egli M; Manoharan M
Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
[TBL] [Abstract][Full Text] [Related]
4. Relative Quantification of siRNA Strand Loading into Ago2 for Design of Highly Active siRNAs.
Angart PA; Adu-Berchie K; Carlson RJ; Vocelle DB; Chan C; Walton SP
Methods Mol Biol; 2019; 1974():41-56. PubMed ID: 31098994
[TBL] [Abstract][Full Text] [Related]
5. siRNA potency enhancement via chemical modifications of nucleotide bases at the 5'-end of the siRNA guide strand.
Shinohara F; Oashi T; Harumoto T; Nishikawa T; Takayama Y; Miyagi H; Takahashi Y; Nakajima T; Sawada T; Koda Y; Makino A; Sato A; Hamaguchi K; Suzuki M; Yamamoto J; Tomari Y; Saito JI
RNA; 2021 Feb; 27(2):163-173. PubMed ID: 33177188
[TBL] [Abstract][Full Text] [Related]
6. Effect of the guide strand 3'-end structure on the gene-silencing potency of asymmetric siRNA.
Hong SW; Park JH; Yun S; Lee CH; Shin C; Lee DK
Biochem J; 2014 Aug; 461(3):427-34. PubMed ID: 24800867
[TBL] [Abstract][Full Text] [Related]
7. Terminal Duplex Stability and Nucleotide Identity Differentially Control siRNA Loading and Activity in RNA Interference.
Angart PA; Carlson RJ; Adu-Berchie K; Walton SP
Nucleic Acid Ther; 2016 Oct; 26(5):309-317. PubMed ID: 27399870
[TBL] [Abstract][Full Text] [Related]
8. Effects of conformational alteration induced by D-/L-isonucleoside incorporation in siRNA on their stability in serum and silencing activity.
Huang Y; Chen Z; Chen Y; Zhang H; Zhang Y; Zhao Y; Yang Z; Zhang L
Bioconjug Chem; 2013 Jun; 24(6):951-9. PubMed ID: 23682837
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure, stability and in vitro RNAi activity of oligoribonucleotides containing the ribo-difluorotoluyl nucleotide: insights into substrate requirements by the human RISC Ago2 enzyme.
Li F; Pallan PS; Maier MA; Rajeev KG; Mathieu SL; Kreutz C; Fan Y; Sanghvi J; Micura R; Rozners E; Manoharan M; Egli M
Nucleic Acids Res; 2007; 35(19):6424-38. PubMed ID: 17881374
[TBL] [Abstract][Full Text] [Related]
10. Investigation of Strand-Selective Interaction of SNA-Modified siRNA with AGO2-MID.
Kamiya Y; Takeyama Y; Mizuno T; Satoh F; Asanuma H
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32717920
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic analysis of the enhanced RNAi activity by 6-mCEPh-purine at the 5' end of the siRNA guide strand.
Brechin V; Shinohara F; Saito JI; Seitz H; Tomari Y
RNA; 2021 Feb; 27(2):151-162. PubMed ID: 33177187
[TBL] [Abstract][Full Text] [Related]
12. The 5' binding MID domain of human Argonaute2 tolerates chemically modified nucleotide analogues.
Deleavey GF; Frank F; Hassler M; Wisnovsky S; Nagar B; Damha MJ
Nucleic Acid Ther; 2013 Feb; 23(1):81-7. PubMed ID: 23289589
[TBL] [Abstract][Full Text] [Related]
13. How to Computationally Stack the Deck for Hit-to-Lead Generation: In Silico Molecular Interaction Energy Profiling for de Novo siRNA Guide Strand Surrogate Selection.
Greenidge PA; Blommers MJJ; Priestle JP; Hunziker J
J Chem Inf Model; 2019 May; 59(5):1897-1908. PubMed ID: 31021613
[TBL] [Abstract][Full Text] [Related]
14. Isonucleotide incorporation into middle and terminal siRNA duplexes exhibits high gene silencing efficacy and nuclease resistance.
Ma Y; Liu S; Wang Y; Zhao Y; Huang Y; Zhong L; Guan Z; Zhang L; Yang Z
Org Biomol Chem; 2017 Jun; 15(24):5161-5170. PubMed ID: 28585968
[TBL] [Abstract][Full Text] [Related]
15. Modification of the siRNA passenger strand by 5-nitroindole dramatically reduces its off-target effects.
Zhang J; Zheng J; Lu C; Du Q; Liang Z; Xi Z
Chembiochem; 2012 Sep; 13(13):1940-5. PubMed ID: 22887813
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis for improved gene silencing by Dicer substrate interfering RNA compared with other siRNA variants.
Snead NM; Wu X; Li A; Cui Q; Sakurai K; Burnett JC; Rossi JJ
Nucleic Acids Res; 2013 Jul; 41(12):6209-21. PubMed ID: 23620279
[TBL] [Abstract][Full Text] [Related]
17. Small interfering RNAs containing full 2'-O-methylribonucleotide-modified sense strands display Argonaute2/eIF2C2-dependent activity.
Kraynack BA; Baker BF
RNA; 2006 Jan; 12(1):163-76. PubMed ID: 16301602
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design of novel chemical modification of the 3'-overhang for optimization of short interfering RNA performance.
Xu L; Wang X; He H; Zhou J; Li X; Ma H; Li Z; Zeng Y; Shao R; Cen S; Wang Y
Biochemistry; 2015 Feb; 54(5):1268-77. PubMed ID: 25635512
[TBL] [Abstract][Full Text] [Related]
19. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing.
Harborth J; Elbashir SM; Vandenburgh K; Manninga H; Scaringe SA; Weber K; Tuschl T
Antisense Nucleic Acid Drug Dev; 2003 Apr; 13(2):83-105. PubMed ID: 12804036
[TBL] [Abstract][Full Text] [Related]
20. Effects of Chemical Modifications on siRNA Strand Selection in Mammalian Cells.
Varley AJ; Hammill ML; Salim L; Desaulniers JP
Nucleic Acid Ther; 2020 Aug; 30(4):229-236. PubMed ID: 32175808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
